Rob Igarashi

Rob Igarashi

Company: Kiadis Pharma

Job title: VP, Discovery & Pre-clinical Development


Roundtable Discussion Session – Innate Vs. Adaptive Immune Cell Types for Allogeneic Therapy 3:00 pm

• Assess the different characteristics of NK, GDT and T cells and how this can impact their success as an allogeneic therapy • Discuss current clinical and preclinical results, specifically assessing the potential to persist and safety profilesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.